Prevent an allergic reaction from happening at school.

Pinnacaine Ear Drops

Generic Name: benzocaine
Dosage Form: otic drops

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Pinnacaine Otic Drops

Pinnacaine Ear Drops Description

ACTIVE INGREDIENT:

Benzocaine.....................20%

in an aqueous base.

Slideshow: Aging Issues: 12 of the Most Common Health Concerns Affecting Seniors

Benzocaine, a local anesthetic, is chemically, ethyl p-aminobenzoate, C9H11NO2, with a molecular weight of 165.19.

INACTIVE INGREDIENTS

Glycerin, Polyethylene Glycol, Benzethonium Chloride, Purified Water.

Pinnacaine Ear Drops - Clinical Pharmacology

Benzocaine acts by blocking conduction in nerve fibers as a result of decreased nerve cell membrane permeability to sodium ions or competition with calcium ions for membrane binding sites.

Indications and Usage for Pinnacaine Ear Drops

Pinnacaine Otic Drops may be used as a topical anesthetic in the external auditory canal to relieve ear pain. It may be used in the treatment of acute otitis media, acute swimmer’s ear and other forms of otitis externa.

Contraindications

Pinnacaine Otic Drops is contraindicated in patients sensitive to benzocaine. This medication should not be applied in the external auditory canal if there is a perforated eardrum or ear discharge.

Warnings

KEEP OUT OF REACH OF CHILDREN. NOT FOR OPHTHALMIC OR ORAL USE.

Use of anesthetic ear drops indiscriminately may mask symptoms of infection of the middle ear.

Precautions

General

Medication should be discontinued if sensitivity or irritation occurs.

Carcinogenesis, Mutagenesis, Impairment of Fertility

Long term studies of animals or humans to evaluate the carcinogenic and mutagenic potential or the effect on fertility have not been conducted.

Pregnancy

Pregnancy Category C:

There are no adequate and well-controlled studies in pregnant women. This product should only be given to pregnant women if clearly needed.

Nursing Mothers

It is not known whether this drug is excreted in human milk. Caution should be used when administered to nursing women.

Pediatric Use

Do not use in infants under 1 year of age.

Adverse Reactions

Benzocaine can cause a hypersensitivity reaction consisting of rash, urticaria and edema. Individuals frequently exposed to ester-type local anesthetics can develop contact dermatitis characterized by erythema and pruritus. Rarely, benzocaine may induce methemoglobinemia causing respiratory distress and cyanosis which can be treated by intravenous methylene blue.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at

1-800-FDA-1088.

Overdosage

Effects of benzocaine overdosage may include yawning, restlessness, excitement, nausea and vomiting. Treatment is symptomatic. Please call your local Poison Control Center or your doctor if you suspect an overdosage of this product.

Pinnacaine Ear Drops Dosage and Administration

Administer 4-5 drops of Pinnacaine Otic Drops in the external ear canal and then insert a cotton pledget into the meatus. Can be repeated every 1 to 2 hours, if necessary.

How is Pinnacaine Ear Drops Supplied

Pinnacaine Otic Drops, NDC# 68047-057-15, is supplied in a 15 mL amber glass bottle with dropper and package insert.

Storage and Handling

Store at 15°-30°C (59°-86°F) [See USP Controlled Room Temperature]. Store in a tight, light-resistant Container. [See USP.} Keep bottle tightly closed.

Distributed by:

Larken Laboratories, Inc.

Canton, MS 39046

Iss. 07/11

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Figure 1: 15 mL container label

Figure 2: 15 mL carton

PENNACAINE 
benzocaine solution/ drops
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:68047-057
Route of Administration AURICULAR (OTIC) DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BENZOCAINE (BENZOCAINE) BENZOCAINE 200 mg  in 1 mL
Inactive Ingredients
Ingredient Name Strength
BENZETHONIUM CHLORIDE  
GLYCERIN  
POLYETHYLENE GLYCOL 400  
WATER  
Packaging
# Item Code Package Description
1 NDC:68047-057-15 1 BOTTLE, DROPPER (BOTTLE) in 1 CARTON
1 15 mL in 1 BOTTLE, DROPPER
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 08/08/2011
Labeler - Larken Laboratories, Inc. (791043719)
Establishment
Name Address ID/FEI Operations
Sonar Products, Inc. 104283945 MANUFACTURE
Revised: 04/2012
 
Larken Laboratories, Inc.

More about Pinnacaine (benzocaine otic)

Consumer resources

Professional resources

Related treatment guides

Hide
(web2)